Demonstrating the Efficacy of a Spanish-Language Program for Latino Dementia Caregivers

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-100
SponsorUniversity of Southern California

About this trial

The investigators will test the efficacy of Unidos en el Cuidado® (United in Caring, herein Unidos), a 3-session, culturally-adapted, group psychoeducational and skill-building intervention for 226 Spanish-speaking family caregivers in California.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

identifies with being Hispanic or Latino descent

speaks and reads Spanish

dementia family caregivers living (or recently lived) in California or whose care recipient lives (or recently lived) in California

who identify as women, men, or non-binary,

Disqualifiers

Severe sensory or physical conditions that interfere with ongoing participation.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Skill-building classes

    Other intervention

    Unidos en el Cuidado is a manualized, multi-family group intervention provided at no cost vis-à-vis videoconferencing or on-site by trained facilitators Sessions are held weekly for 1.5 hours. Class components include caregiver role identity; skills-building; knowledge attainment; attitudinal changes; resource-sharing; practice/role-plays; homework; videos, handouts. Classes will be provided online with some classes offered in the community, if available

  • Wait list control group

    Other intervention

    The intervention is the same; the wait period is longer to receive the intervention described in Group A.

Treatment groups

225 Participants
are divided into 2 treatment groups
Group A: Group A: Treatment Group Receives the Classes Soon after RandomizationExperimental treatment 1 intervention
Group B: Group B: Wait List Control Group Receives the Classes after a Waiting PeriodActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Depressive symptoms

Patient Health Questionnaire 9 item standardized scale: min. to max values=0 to 27; higher values indicate worse outcomes

Time frame
baseline; post-intervention (within 1 week of completing intervention); 3-months; 6-months from baseline
2

Presence and reaction to memory and behavior problems shown by person with dementia

Revised Memory and Behavior Problems Checklist standardized scale: 1. Symptom presence (yes/no); min. to max values=0 to 24; higher values indicate worse outcomes 2. Symptom reaction: Include only items with frequency scores of 1 to 4 in the reaction scoring. Compute the mean reaction score by summing reaction scores of these items and then dividing by the number of items included in the sum. the range for each subscale is 0 to 4. Higher values indicate worse outcomes

Time frame
baseline; post-intervention (within 1 week of completing intervention); 3-months; 6-months from baseline
3

Anxiety symptoms

Generalized Anxiety Disorder 7 item standardized scale: min. to max values=0 to 24; higher values indicate worse outcomes

Time frame
baseline; post-intervention (within 1 week of completing intervention); 3-months; 6-months from baseline

Secondary outcomes

1

Caregiver Mastery

Caregiver Mastery standardized scale: min. to max values=0 to 12; higher values indicate better outcomes

Time frame
baseline; post-intervention (within 1 week of completing intervention); 3-months; 6-months from baseline
2

Caregiver Competence

Caregiver Competence standardized scale: min. to max values=0 to 12; higher values indicate better outcomes

Time frame
baseline; post-intervention (within 1 week of completing intervention); 3-months; 6-months from baseline
3

Caregiver Meaning

Caregiver Meaning standardized scale: min. to max values=0 to 24; higher values indicate better outcomes

Time frame
baseline; post-intervention (within 1 week of completing intervention); 3-months; 6-months from baseline

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Southern California

Lead sponsor

California Department of Public Health

Collaborator